BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang GY, Guo S, Dong CY, Wang XQ, Hu BY, Liu YF, Chen YW, Niu J, Dong JH. Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression. World J Gastroenterol 2015; 21(24): 7457-7467 [PMID: 26139991 DOI: 10.3748/wjg.v21.i24.7457]
URL: https://www.wjgnet.com/1007-9327/full/v21/i24/7457.htm
Number Citing Articles
1
Alexandra Desnoyers, Carlos González, Pedro Pérez-Segura, Atanasio Pandiella, Eitan Amir, Alberto Ocaña. Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-AnalysisMolecular Diagnosis & Therapy 2020; 24(2): 143 doi: 10.1007/s40291-020-00450-1
2
Beatrice S. Ludwig, Horst Kessler, Susanne Kossatz, Ute Reuning. RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving FieldCancers 2021; 13(7): 1711 doi: 10.3390/cancers13071711
3
Yunyu Lian, Silue Zeng, Sai Wen, Xingyang Zhao, Chihua Fang, Ning Zeng. Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal AdenocarcinomaTechnology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231189399
4
Tanushree Ganguly, Nadine Bauer, Ryan A. Davis, Cameron C. Foster, Rebecca E. Harris, Sven H. Hausner, Emilie Roncali, Sarah Y. Tang, Julie L. Sutcliffe. Preclinical Evaluation of68Ga- and177Lu-Labeled Integrin αvβ6-Targeting Radiotheranostic PeptidesJournal of Nuclear Medicine 2023; 64(4): 639 doi: 10.2967/jnumed.122.264749
5
Pengwei Yan, Huanfeng Zhu, Li Yin, Lijun Wang, Peng Xie, Jinjun Ye, Xuesong Jiang, Xia He. Integrin αvβ6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8–Mediated MAPK/ERK SignalingTranslational Oncology 2018; 11(3): 619 doi: 10.1016/j.tranon.2018.02.013
6
Leila Mohammadi, Bashir Mosayyebi , Mahsa Imani, Mohammad Rahmati . Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer Cell LineAnti-Cancer Agents in Medicinal Chemistry 2022; 22(13): 2494 doi: 10.2174/1871520621666201214150427
7
Samy A.F. Morad, Lance C. Bridges, Alex D. Almeida Larrea, Anthony L. Mayen, Matthew R. MacDougall, Traci S. Davis, Mark Kester, Myles C. Cabot. Short-chain ceramides depress integrin cell surface expression and function in colorectal cancer cellsCancer Letters 2016; 376(2): 199 doi: 10.1016/j.canlet.2016.03.049
8
Shunsuke Nakamura, Aya Matsuno, Masashi Ueda. Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acidsAnnals of Nuclear Medicine 2020; 34(8): 575 doi: 10.1007/s12149-020-01483-6
9
Zequn Li, Pengfei Lin, Chao Gao, Cheng Peng, Song Liu, Huijie Gao, Ben Wang, Jiayong Wang, Jun Niu, Weibo Niu. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC)Tumor Biology 2016; 37(4): 5117 doi: 10.1007/s13277-015-4353-7
10
Ping-Hsiu Wu, Abayomi Emmanuel Opadele, Yasuhito Onodera, Jin-Min Nam. Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and TherapyCancers 2019; 11(11): 1783 doi: 10.3390/cancers11111783
11
Tatiana S. Gerashchenko, Nikita M. Novikov, Nadezhda V. Krakhmal, Sofia Y. Zolotaryova, Marina V. Zavyalova, Nadezhda V. Cherdyntseva, Evgeny V. Denisov, Vladimir M. Perelmuter. Markers of Cancer Cell Invasion: Are They Good Enough?Journal of Clinical Medicine 2019; 8(8): 1092 doi: 10.3390/jcm8081092
12
Eiki Ichihara, David Westover, Catherine B. Meador, Yingjun Yan, Joshua A. Bauer, Pengcheng Lu, Fei Ye, Amanda Kulick, Elisa de Stanchina, Robert McEwen, Marc Ladanyi, Darren Cross, William Pao, Christine M. Lovly. SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung CancerCancer Research 2017; 77(11): 2990 doi: 10.1158/0008-5472.CAN-16-2300
13
Fanni Li, Yukui Shang, Feiyu Shi, Lei Zhang, Jun Yan, Qi Sun, Junjun She. <p>Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma</p>Cancer Management and Research 2020; : 9599 doi: 10.2147/CMAR.S274892
14
Ian I. Cardle, Michael C. Jensen, Suzie H. Pun, Drew L. Sellers. Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targetingJournal of Biological Chemistry 2021; 296: 100657 doi: 10.1016/j.jbc.2021.100657
15
Jian-Rui Chen, Jing-Tong Zhao, Zhen-Zhen Xie. Integrin-mediated cancer progression as a specific target in clinical therapyBiomedicine & Pharmacotherapy 2022; 155: 113745 doi: 10.1016/j.biopha.2022.113745
16
Markus Nieberler, Ute Reuning, Florian Reichart, Johannes Notni, Hans-Jürgen Wester, Markus Schwaiger, Michael Weinmüller, Andreas Räder, Katja Steiger, Horst Kessler. Exploring the Role of RGD-Recognizing Integrins in CancerCancers 2017; 9(9): 116 doi: 10.3390/cancers9090116
17
Lixing Ma, Kang Song, Jinfeng Zang. Integrin β5 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese populationExperimental and Therapeutic Medicine 2023; 26(5) doi: 10.3892/etm.2023.12231
18
Nisar Ul Khaliq, Laraib Amin, Saad Ul Khaliq, Anam Amin, Samreen Omer, Ihtisham Ul Khaliq, Yejin Kim, Joohyeon Kim, Taeho Kim, Dongseong Seo, Daekyung Sung, Hyungjun Kim. Peptide-Based Prodrug Approaches for Cancer NanomedicineACS Applied Bio Materials 2024; 7(12): 8163 doi: 10.1021/acsabm.4c01364
19
Naomi O. Hodgins, Wafa' T. Al-Jamal, Julie T.-W. Wang, Rebecca Klippstein, Pedro M. Costa, Jane K. Sosabowski, John F. Marshall, John Maher, Khuloud T. Al-Jamal. Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapyJournal of Controlled Release 2017; 256: 141 doi: 10.1016/j.jconrel.2017.04.025
20
Long Zhao, Linxuan Huang, Shuyi Yu, Junheng Zheng, Hua Wang, Yan Zhang. Decellularized tongue tissue as an in vitro model for studying tongue cancer and tongue regenerationActa Biomaterialia 2017; 58: 122 doi: 10.1016/j.actbio.2017.05.062
21
Yurie Soejima, Miho Takeuchi, Nao Miyamoto, Motoji Sawabe, Toshio Fukusato. ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 ExpressionInternational Journal of Molecular Sciences 2021; 22(12): 6303 doi: 10.3390/ijms22126303
22
Hao Liu, Liquan Gao, Xinhe Yu, Lijun Zhong, Jiyun Shi, Bing Jia, Nan Li, Zhaofei Liu, Fan Wang. Small-animal SPECT/CT imaging of cancer xenografts and pulmonary fibrosis using a 99mTc-labeled integrin αvβ6-targeting cyclic peptide with improved in vivo stabilityBiophysics Reports 2018; 4(5): 254 doi: 10.1007/s41048-018-0071-1